Pfizer discontinues GLP-1 pill trial, stock trades flat [Yahoo! Finance Canada]
Pfizer, Inc. (PFE)
Last pfizer, inc. earnings: 4/28 06:45 am
Check Earnings Report
US:NYSE Investor Relations:
investors.pfizer.com/investors-overview/default.aspx
Company Research
Source: Yahoo! Finance Canada
Pfizer ( PFE ) announced early Monday that it is halting a late-stage trial of its GLP-1 pill candidate, danuglipron, dashing hopes of the company entering the obesity space in the near term. A trial participant in the phase III trial of its once-daily pill experienced "potential drug-induced liver injury" that disappeared after the participant stopped the pill, the company said in a statement. "While we are disappointed to discontinue the development of danuglipron, we remain committed to evaluating and advancing promising programs in an effort to bring innovative new medicines to patients," Pfizer chief scientific officer Chris Boshoff said. The company had hoped to compete in the obesity space and had been optimistic in recent public statements about the po
Read more
Impact Snapshot
Event Time:
PFE
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
PFE alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
PFE alerts
High impacting Pfizer, Inc. news events
Weekly update
A roundup of the hottest topics
PFE
News
- Pfizer (PFE) Stock Sinks As Market Gains: What You Should Know [Yahoo! Finance]Yahoo! Finance
- Pfizer Declares Second-Quarter 2025 DividendBusiness Wire
- Pfizer Advances Bold Vision for Future of Cancer Care at the ASCO 2025 Annual MeetingBusiness Wire
- Pfizer Stock Before Q1 Earnings Release: To Buy or Not to Buy? [Yahoo! Finance]Yahoo! Finance
- Pfizer Inc. (NYSE: PFE) is now covered by analysts at Cantor Fitzgerald. They set a "neutral" rating and a $24.00 price target on the stock.MarketBeat
PFE
Earnings
- 2/4/25 - Beat
PFE
Sec Filings
- 4/17/25 - Form 4
- 4/14/25 - Form 4
- 4/11/25 - Form DEFA14A
- PFE's page on the SEC website